Strong Full-Year Revenue Growth
Full year 2025 revenue of $21.0M versus a little over $2M in 2024 — described as nearly tenfold year-over-year growth; Q4 2025 revenue was $4.6M, a $2.6M (124%) increase year-over-year.
High Full-Year Gross Margins (Driven by Services)
Full year GAAP gross margin was 53.8% and non-GAAP gross margin was 55.7% for 2025 (reflecting high-margin service contributions in the year).
Operating Expense Reductions and Improved Profitability Trends
Q4 2025 GAAP operating expenses were $18.2M (down 40% YoY from $30.4M); Q4 non-GAAP operating expenses were $13.5M (down 44% YoY). Full year GAAP Opex declined 15% to $93.9M and non-GAAP Opex declined 11% to $73.0M versus 2024.
Improved Adjusted EBITDA and Net Loss Metrics
Q4 adjusted EBITDA loss improved to $13.8M (40% improvement vs prior-year quarter). Full-year adjusted EBITDA loss improved to $52.6M (23% improvement YoY). GAAP net loss for 2025 was $73M ($0.22/sh) vs $100.2M ($0.31/sh) in 2024.
Strong Liquidity Position
Exited 2025 with $200M in liquidity (at the top end of prior expectation of $195M–$200M), providing runway for 2026 initiatives and CapEx-light execution.
UZ Energy Acquisition and Early Commercial Wins
Acquisition of UZ Energy contributed ~3.5 months of 2025 revenue; UZ signed a multiyear $20M contract with a major distributor and has historical shipments totaling almost a gigawatt-hour of hardware across multiple regions.
Molecular Universe Progress and Customer Interest
Molecular Universe discovered six electrolyte/material breakthroughs currently being tested by over 40 customers; MU SaaS revenue is building and MU is positioned as an IP/data asset with potential standalone value.
2026 Guidance Reflects Continued Growth
Company expects 2026 revenue of $30M–$35M, representing ~43%–67% growth over 2025; consolidated gross margin expected to be ~15% with potential to improve as attach rates and scale increase.
CapEx-Light Strategy and Controlled Cash Deployment
2025 cash usage included $58.4M used in operations, $3.3M deployed on the UZ acquisition, $2.9M CapEx, and $1.6M returned via share repurchases; 2026 CapEx expected to remain in the single-digit millions focused on Korea conversion and contract manufacturer evaluation.
NDAA-Compliant Manufacturing Asset
Chungju, South Korea facility has been NDAA-compliant since 2021 and is being positioned for conversion to NDAA-compliant drone cell production; company is pursuing additional Southeast Asia capacity.